Prospective non-interventional double study about gender specific differences in the treatment of colorectal cancer - Version: Treatment with Irinotecan containing regimens LIV Pharma

Interventions: Group 1: This non-interventional study is observing a patient population with histologically or cytologically diagnosed colorectal cancer, for which the treatment with Irinotecan LIV Pharma is indicated according to SPC
There are the special warnings and precautions for use in the SPC of Irinotecan LIV to be addressed.
Primary outcome(s): Efficacy and Tolerability routine practice. Observational, non-interventional study. In detail: Was therapy completed as planned and what was the response.
Study Design: Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: treatment